Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tradr 2X Short TSLA Daily ETF
TSLQ
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
CPRX Catalyst Pharmaceuticals
- 24.280
- +0.650+2.75%
Close Apr 29 16:00 ET
- 24.350
- +0.070+0.29%
Post 20:01 ET
2.96BMarket Cap18.53P/E (TTM)
24.460High23.410Low717.62KVolume23.530Open23.630Pre Close17.33MTurnover0.64%Turnover Ratio18.53P/E (Static)121.96MShares26.15852wk High4.07P/B2.74BFloat Cap14.47052wk Low--Dividend TTM112.80MShs Float26.158Historical High--Div YieldTTM4.44%Amplitude0.370Historical Low24.145Avg Price1Lot Size
About Catalyst Pharmaceuticals Company
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Company Profile
SymbolCPRX
Company NameCatalyst Pharmaceuticals
Listing DateNov 8, 2006
Issue Price6.00
Founded2002
CEOMr. Richard J. Daly
MarketNASDAQ
Employees181
Fiscal Year Ends12-31
Address355 Alhambra Circle,Suite 801
CityCoral Gables
ProvinceFlorida
CountryUnited States of America
Zip Code33134
Phone1-305-420-3200
Company Executives
- Name
- Position
- Salary
- Richard J. Daly
- Director, President and Chief Executive Officer
- 7.77M
- Michael W. Kalb, C.P.A.
- Executive Vice President,Treasurer, Chief Financial Officer and Principal Accounting Officer
- 6.18M
- Jeffrey Del Carmen
- Executive Vice President and Chief Commercial Officer
- 2.64M
- Gregg Russo
- Chief Human Resources Officer
- --
- Brian Elsbernd, J.D.
- Chief Compliance Officer and Chief Legal Officer
- --
- Dr. Steven R. Miller,PhD
- Executive Vice President, Chief Operating Officer and Chief Scientific Officer
- 3.55M
- Dr. Preethi Sundaram, PhD
- Chief Strategy Officer
- 2.53M
- Dr. Gary Ingenito,M.D.,PhD
- Chief Medical and Regulatory Officer
- --
- Patrick J. McEnany
- Non-Executive Chairman of the Board
- 844.76K
- Charles B. O'Keeffe
- Lead Independent Director
- 408.64K
- Tamar Thompson
- Independent Director
- 381.02K
- Molly Harper
- Independent Director
- 439.14K
- Donald A. Denkhaus
- Independent Director
- 386.27K
- Dr. David S. Tierney,M.D.
- Independent Director
- 381.02K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
